Quanterix Accelerator Laboratory Gains New York State Clinical Lab Permit
The CLIA-certified facility is now authorized to operate in all 50 states, expanding biomarker testing capabilities nationwide.
Read MorePosted by Edisource Vendor | Aug 25, 2025 | Accreditation |
The CLIA-certified facility is now authorized to operate in all 50 states, expanding biomarker testing capabilities nationwide.
Read MorePosted by Edisource Vendor | Aug 25, 2025 | Prostate |
The risk stratification tool is designed to predict long-term outcomes for patients with non-metastatic prostate cancer.
Read MorePosted by Edisource Vendor | Aug 22, 2025 | Company News |
Cancer diagnostics company adds three clinical advisors and two board members to support commercial growth and platform expansion.
Read MorePosted by Edisource Vendor | Aug 21, 2025 | Information Technology |
The cloud-based EHR platform now offers real-time lab ordering and results delivery, eliminating the need for separate portals or fax-based communication.
Read MorePosted by Edisource Vendor | Aug 21, 2025 | POC Rapid Assays |
The app integrates rapid diagnostic testing, artificial intelligence, and telehealth capabilities, while the company’s decentralized clinical trial platform aims to reduce study costs and improve data collection.
Read More